UPDATE: BTIG Initiates Coverage On Pharmacyclics By: Benzinga via Benzinga January 06, 2015 at 07:38 AM EST BTIG initiated coverage on Pharmacyclics, Inc. (NASDAQ: PCYC) Monday with a Buy rating and $225 price target. Analyst Hartaj ... Read More >>